Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Assets (2019 - 2025)

Silo Pharma's Return on Assets history spans 7 years, with the latest figure at 0.78% for Q3 2025.

  • For Q3 2025, Return on Assets fell 33.0% year-over-year to 0.78%; the TTM value through Sep 2025 reached 0.78%, down 33.0%, while the annual FY2024 figure was 0.58%, 57.0% down from the prior year.
  • Return on Assets for Q3 2025 was 0.78% at Silo Pharma, roughly flat from 0.78% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q4 2022 and bottomed at 0.78% in Q2 2025.
  • The 5-year median for Return on Assets is 0.36% (2023), against an average of 0.34%.
  • The largest annual shift saw Return on Assets surged 183bps in 2021 before it crashed -54bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.04% in 2021, then surged by 100bps to 0.0% in 2022, then plummeted by -575629bps to 0.54% in 2023, then dropped by -1bps to 0.55% in 2024, then tumbled by -42bps to 0.78% in 2025.
  • Per Business Quant, the three most recent readings for SILO's Return on Assets are 0.78% (Q3 2025), 0.78% (Q2 2025), and 0.69% (Q1 2025).